North America Free Trade Agreement | US-Mexico-Canada Agreement
"The data localization and data transfer rules may erode efforts to safeguard privacy and many other provisions represent a lost opportunity to establish higher standards," says expert
The intensifying debate over the renegotiated NAFTA that President Trump is seeking to rebrand as the United States-Mexico-Canada Agreement (USMCA) suggests that the president’s trade policy is not so different from those of his predecessors.
More than six months after the United States, Mexico and Canada agreed a new deal, the chances of the countries ratifying the pact in 2019 are receding.
USMCA bears many resemblances to NAFTA, which has been cited as a driver of low-wage corporate outsourcing.
US House Speaker Nancy Pelosi said lawmakers could not take up the replacement for NAFTA unless Mexico passes legislation protecting workers’ rights. She also cited concerns over enforcement provisions, among other issues.
The Parliamentary Budget Officer (PBO) revealed that new intellectual property provisions in the Canada-United States-Mexico Agreement would cost Canadians as much as $169 million more per year for pharmaceutical drugs
The new version of NAFTA forbids the US Congress from curtailing Big Pharma’s patent monopolies on some of the world’s most expensive drugs.
The US company notified its intention to claim compensation of 3,540 million dollars from the Mexican government.
The US Department of Agriculture’s undersecretary for trade said he doubts the trilateral deal would be ratified before the upcoming Canadian federal election. Canadians head to the polls on Oct. 22.
Economists who examined the text of the trade deal say that even if it helps the overall U.S. economy, the impact will likely be "tiny." And some economists say there is a good chance it will hurt the American economy.
US Court of International Trade rules use of national security tariffs allowed, but appeal likely
A workshop aimed to promote a collective analysis of border control, focusing on the power and impunity of transnational corporations, militarization, the externalization of borders, and the link between free trade and migration.
Several Democrats said a closed-door meeting between United States Trade Representative failed to ease their concerns about the new US-Mexico-Canada Agreement’s provisions on labor, biologic drugs and some other issues.
Les sociétés minières canadiennes ont encore mauvaise presse au Mexique, car elles ne respecteraient pas les droits de peuples autochtones.
Sharon Treat exposes another backdoor to deregulation, the Regulatory Cooperation Council, that exists through NAFTA and is being used by corporate livestock lobbyists to undermine food safety and consumers right to know.
Unless the Trump administration lifts the punishing tariffs it has imposed on Mexican steel and aluminum imports, Mexico is prepared to keep the status quo with the 25-year-old trade deal.
Faced with real 21st century problems — climate change and global inequality exacerbated by globalization and trade agreements — we cannot accept this unambitious agreement which fails to live up to major existential challenges.
Long-running case began after New Jersey company’s bid to open a quarry in Nova Scotia rejected in 2007
Mexico has signed 12 free trade agreements with 44 nations and 28 bilateral investment treaties. The grim consequences of globalization in Mexico are by now familiar and yet, throughout Mexico, there is a florescence of inspiring resistance and alternatives.
Democrats in Congress contend that the new pact would force Americans to pay more for prescription drugs, and their argument has dimmed the outlook for one of Trump’s signature causes.